Eris Lifesciences Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 25, 2025
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences held its 19th Annual General Meeting on July 25, 2025, via video conferencing, lasting just 20 minutes (11:00 AM to 11:20 AM). Shareholders adopted the audited standalone and consolidated financial statements for FY ended March 31, 2025. M/s. Walker Chandiok & Co. LLP was appointed as Statutory Auditor for a five-year term (FY 2025-26 to FY 2029-30), and M/s. Ravi Kapoor & Associates was appointed as Secretarial Auditors for the same period. The remuneration of Cost Auditors for FY 2025-26 was also ratified. Additionally, Mr. Amit Bakshi was re-appointed as Managing Director, while Mr. Inderjeet Singh Negi and Mr. Kaushal Kamlesh Shah were re-appointed as Whole-Time Directors. All resolutions were transacted through remote e-voting and e-voting at the meeting, with voting results to be disclosed separately.
This is a routine procedural filing confirming that standard AGM business — including board re-appointments and auditor confirmations — was conducted. The re-appointment of the existing leadership team signals continuity in management, and the appointment of new statutory and secretarial auditors for a five-year term brings stability in audit oversight. No material impact on shareholders is expected from this announcement alone.